Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: 1 hour ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR1672Referred to Committee

Maintaining Investments in New Innovation Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-02-27
Introduced
46
Cosponsors
HR
ⓘ
Type

Sponsor

Donald G. Davis
Donald G. Davis
Democrat · NC · Representative
Votes with party: 79.5% (594 recorded votes)
Top industries funding sponsor:
  • Progressive Groups$238k

Full profile: /officials/D000230

Source: Congress.gov · FEC

Cosponsors (46)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • Aaron Bean (R-FL-4)Original· 2025-02-27
  • Beth Van Duyne (R-TX-24)Original· 2025-02-27
  • Blake D. Moore (R-UT-1)Original· 2025-02-27
  • Claudia Tenney (R-NY-24)Original· 2025-02-27
  • Dan Crenshaw (R-TX-2)Original· 2025-02-27
  • John Joyce (R-PA-13)Original· 2025-02-27
  • Joseph D. Morelle (D-NY-25)Original· 2025-02-27
  • Josh Gottheimer (D-NJ-5)Original· 2025-02-27
  • Mariannette Miller-Meeks (R-IA-1)Original· 2025-02-27
  • Richard Hudson (R-NC-9)Original· 2025-02-27
  • Rick W. Allen (R-GA-12)Original· 2025-02-27
  • Rudy Yakym III (R-IN-2)Original· 2025-02-27
  • Scott H. Peters (D-CA-50)Original· 2025-02-27
  • Neal P. Dunn (R-FL-2)· 2025-03-27
  • Kevin Hern (R-OK-1)· 2025-04-09
  • Mike Carey (R-OH-15)· 2025-04-10
  • Jefferson Shreve (R-IN-6)· 2025-05-09
  • August Pfluger (R-TX-11)· 2025-05-13
  • Pete Sessions (R-TX-17)· 2025-06-04
  • Addison P. McDowell (R-NC-6)· 2025-06-10
  • Mike Kelly (R-PA-16)· 2025-09-02
  • Charles J. "Chuck" Fleischmann (R-TN-3)· 2025-09-17
  • Brittany Pettersen (D-CO-7)· 2025-09-30
  • Daniel Meuser (R-PA-9)· 2025-09-30
  • Nicole Malliotakis (R-NY-11)· 2025-09-30
  • Troy Balderson (R-OH-12)· 2025-10-03
  • Tim Moore (R-NC-14)· 2025-10-17
  • Chuck Edwards (R-NC-11)· 2025-10-31
  • John R. Moolenaar (R-MI-2)· 2025-10-31
  • Ken Calvert (R-CA-41)· 2025-10-31
  • Randy K. Weber, Sr. (R-TX-14)· 2025-10-31
  • Vince Fong (R-CA-20)· 2025-11-04
  • Brian Jack (R-GA-3)· 2025-11-10
  • Nathaniel Moran (R-TX-1)· 2025-11-17
  • Laurel M. Lee (R-FL-15)· 2025-11-21
  • Mike Haridopolos (R-FL-8)· 2025-11-21
  • Thomas H. Kean, Jr. (R-NJ-7)· 2025-11-21
  • Ashley Hinson (R-IA-2)· 2025-12-04
  • Kevin Mullin (D-CA-15)· 2025-12-09
  • Michael Lawler (R-NY-17)· 2026-01-13
  • Andy Barr (R-KY-6)· 2026-03-20
  • Gus M. Bilirakis (R-FL-12)· 2026-04-15

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2025-02-27

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on Energy and CommerceReferred To · 2025-02-27
  • House Committee on Ways and MeansReferred To · 2025-02-27

Previously

  • Energy and Commerce CommitteeReferred To · 2025-02-27
  • Ways and Means CommitteeReferred To · 2025-02-27

Plain-English Summary

Maintaining Investments in New Innovation Act This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.)

Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HR9668STOP Senior Fraud Act
    Referred to Committee · 2026-07-14
  • HRES1293Recognizing and celebrating "National Salvation Army Week" on May 11 through May 17, 2026.
    Referred to Committee · 2026-05-15
  • HR7530Assistance for Rural Water Systems Act of 2026
    Referred to Committee · 2026-03-20
  • HR6433Rural Uplift and Revitalization Assistance Act
    Referred to Committee · 2026-01-13